CCDC77

Across TCGA pan-cancer cohorts, CCDC77 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated CCDC77 data layer compared with 24 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher CCDC77 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated CCDC77 expression acts as an unfavorable survival marker, although some lineages such as LUAD and HNSC show a favorable association.

LUAD, HNSC, and CCRCC are the cancer types where CCDC77 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	II,III,IV	1.000	0.795	.022	3	view →
HNSC	DFS	Median	All	0.762	0.451	.022	3	view →
CCRCC	DFS	Quartile	All	1.000	0.571	.036	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

CCDC77–LUAD (DFS)

Open the LUAD breakdown →